Improvements in pancreatic imaging have had a considerable impact on c
linical practice. Helical computed tomography scanning and endoscopic
ultrasonography have emerged as sensitive and accurate for pancreatic
imaging. The development of endoscopic ultrasonography-guided biopsy n
ow allows the provision of both tissue diagnosis and staging informati
on in a single procedure. Positron emission tomography has demonstrate
d the potential to differentiate inflammatory from malignant lesions,
an important and difficult clinical problem. Ultrasound probes are und
er development for both intraductal and endovascular imaging. In the e
valuation of neuroendocrine tumors, a prominent role for endoscopic ul
trasonography has emerged and nuclear receptor scintigraphy has shown
promise as a noninvasive imaging modality in selected patients. The ro
le of magnetic resonance pancreatic imaging continues to be refined.